-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.
Highlights from Western Veterinary Conference 2023
- Share
- Tweet
- Share on Facebook
- Share
A video highlighting Volition’s attendance at the 2023 Western Veterinary Conference, including the Nu.Q® Vet Cancer Test being available for pre-order at the point-of-care from Heska. Watch to hear from Heska’s colleagues, Volition Veterinary Chief Operating Officer, Dr. Tom Butera, Dr. Sue Ettinger, aka Dr. Sue Cancer Vet, and various veterinarians.
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields